CutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals


WOBURN, Mass.–(BUSINESS WIRE)–CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Pharmaceuticals. “I am thrilled to announce the combination of two strong companies with a rich legacy meeting the needs of underserved patients, such as children and the elderly,” said Neal I. Muni, MD, MSPH, Azurity Pharmaceuticals’ Chief Executive Officer. “Azurity’s mission, to make safe, …..